CHINALI, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 1.408
EU - Europa 709
AS - Asia 263
AF - Africa 5
OC - Oceania 3
SA - Sud America 2
Totale 2.390
Nazione #
US - Stati Uniti d'America 1.375
SE - Svezia 257
CN - Cina 145
IE - Irlanda 92
UA - Ucraina 92
FI - Finlandia 80
SG - Singapore 78
DE - Germania 65
NL - Olanda 50
IT - Italia 45
CA - Canada 32
IN - India 19
GB - Regno Unito 18
VN - Vietnam 12
RU - Federazione Russa 4
CI - Costa d'Avorio 3
AT - Austria 2
BR - Brasile 2
FR - Francia 2
HK - Hong Kong 2
MA - Marocco 2
NZ - Nuova Zelanda 2
TR - Turchia 2
TW - Taiwan 2
AU - Australia 1
DK - Danimarca 1
GE - Georgia 1
IL - Israele 1
KR - Corea 1
PA - Panama 1
PT - Portogallo 1
Totale 2.390
Città #
Chandler 333
Jacksonville 154
Millbury 95
Princeton 80
Ashburn 75
Amsterdam 50
Ann Arbor 50
Nanjing 46
Singapore 46
Boston 42
Boardman 36
Kronberg 36
Woodbridge 35
Houston 34
Wilmington 32
Ottawa 27
Nanchang 20
Pune 19
Falls Church 16
Shenyang 16
Seattle 14
Dong Ket 12
Hebei 11
Beijing 10
Washington 10
Changsha 9
Kunming 8
Tianjin 8
Los Angeles 7
Norwalk 7
Napoli 6
Jiaxing 5
Mountain View 5
Naples 4
Cologne 3
Dallas 3
Hangzhou 3
Redmond 3
Shanghai 3
Berlin 2
Bologna 2
Dublin 2
Hong Kong 2
Lanzhou 2
Liverpool 2
Milan 2
Torino 2
Auckland 1
Bergamo 1
Cerritos 1
Changchun 1
Charleville 1
Christchurch 1
Copenhagen 1
Dartmouth 1
Faro 1
Forlì 1
Gosport 1
Izhevsk 1
Jinan 1
Leicester 1
Manassas 1
Messines 1
Miami 1
Moscow 1
Natal 1
New York 1
Nuremberg 1
Padova 1
Panama City 1
Québec 1
Sault Ste. Marie 1
Senigallia 1
Seoul 1
Seriate 1
Siracusa 1
Taipei 1
Tbilisi 1
Tel Aviv 1
Toronto 1
Tullamore 1
Vienna 1
Vila Velha 1
Walnut 1
Yaroslavl 1
Totale 1.427
Nome #
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. 64
Evaluation of concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation 60
Association of suboptimal blood pressure control with body size and metabolic abnormalities. 59
Estimate of White-coat Effect and Arterial Stiffness 58
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. 54
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities 54
Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the strong heart study. 51
Left Atrial Systolic Force and Cardiac Markers of Preclinical Disease in Hypertensive Patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study 50
Association of Blood Pressure With Blood Viscosity in American Indians. The Strong Heart Study 49
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. 49
Risk factors for arterial hypertension in adults with initial optimal bloodpressure: the Strong Heart Study. 49
Left Ventricular Mass Is a Predictor of Follow-Up Uncontrolled Blood Pressure in Hipertensive Patients. 49
2D Speckle Strain Immaging Identifies Depressed Left Atrial function in Hypertensive Patients with Diastolic Dysfunction 48
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. 47
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated framingham risk score in individuals with dyslipidemia. 47
Reduced Systolic Myocardial Function in Children with Chronic Renal Insufficiency 41
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE Study. 41
Association of Insuline Resistance with Preclinical Cardiovascular Disease in Adolescent and young Adults: the Strong Heart Study 41
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study) 39
Cardiac markers of preclinical disease in adolescents with the metabolic syndrome: the strong heart study. 39
Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population with High Prevalence of Obesity and Diabetes: The Strong Heart Study. 38
Atrial Strain by 2d Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 38
Statins and Incident Diabetes 38
Aortic Dilatation in Normotensive or Hypertensive Adolescents and Young Adults: The Strong Heart Study 37
Preclinical Systolic Dysfunction In Patients With Stage 3 Chronic Renal Disease 36
Atrial Strain by 2D Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 35
Increased Left ventricular Mass and Control of Arterial Hypertension in Hypertensive Patients 35
Sex Differences in Obesity-Related Changes in Left Ventricular Morphology : the Strong Heart Study. 35
Addition of Canrenone to optimal therapy improves cardiac geometry and function in patients with systolic heart failure and metabolic syndrome: The AREA-IN-CHF Study 34
Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Renal Disease. 34
Cardiac Remodeling and Diastolic Dysfunction Precede non MI-Related Heart Failure in High-Risk Hypertensive Patients: the LIFE Echo Substudy 34
Depressed Cardiac Mechanics in Hypertensive Patients with Moderate Chronic Renal Insufficiency: A Speckle-Strain Study 34
Predictors of Lack of Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients. 33
Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? 32
Left Venticular Hypertrophy and Carotid Atherosclerosis as Predictors of New-Onset Diabetes 32
Relationship between Myocardial Mechanical Efficiency and Cardiac Phenotype in Hypertensive Adults: the Campania Salute Network. 32
Left Atrial Systolic Force: Comparison Between Two Methods for the Noninvasive assesment of Left Atrial Systolic Function 30
The Issue of Body Size Between Methods and Substance. 29
2d Speckle Strain Imaging Identifies Depressed Left Atrial Function in Hypertensive Patients with Diastolic Dysfunction 29
Does Additional Echocardiographic Information Improve Prediction of Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension? 28
Left Ventricular Mass Predicts Heart Failure not related to Previous Miocardial Infarction: The Cardiovascular Health Study. 26
New-onset diabetes and uncontrolled blood pressure 26
Non Invasive Evaluation of Myocardial Stiffness in Arterial Hypertension. 26
Correlation among renal and cardiac function and left ventricular geometries: The Strong Heart Study. 25
Incident Diabetes in Hypertensive Patients with Uncontrolled Blood Pressure 25
Increased left ventricular mass in pre-liver transplantation cirrhotic patients. 24
Myocardial mechano-energetic efficiency in hypertensive adults 24
Cardiovascular phenotype predicting incident heart failure in diabetes: The Strong Heart Study. 24
Statins therapy in atrial fibrillation in hypertensive patients. 24
Hypokalemia Blunts Left Ventricular Mass Regression in Hypertensive Patients During Losartan or Atenolol-Based Treatment: The Life Echo-Substudy 24
Combination of left atrial size and function improves prediction of incident heart failure: The Strong Heart Study. 23
Prevalence and Correlation of Aortic Dilatation in Adolescents and Young Adults: the Strong Heart Study 23
Two Dimensional Speckle Strain Imaging Identifies Depressed Left Atrial Function in Hypertensive Patients with Diastolic Dysfunction 23
Cardiovascular and metabolic predictors of progression to overt hypertension in a population with basal high-normal blood pressure levels: The Strong Heart Study 22
Cardiac modifications related to incident heart failure in treated hypertensive patients: the LIFE Echo Substudy. 22
Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the strong heart study 21
Insufficient control of blood pressure and incident diabetes 21
Impact of left ventricular geometry on myocardial mechanical efficiency in hypertensive patients 21
Combination of left atrial size and function improves prediction of incident heart failure: the Strong Heart Study. 21
Hypokalemia blunts left ventricular mass regression in hypertensive patients during Losartan- or Atenolol-based treatment: The LIFE Echo-substudy 21
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during anti-hypertensive treatment: the LIFE Eco-substudy. 19
Increased Left Ventricular Mass in Hypertensive Men Is More Strongly Related to Central than to Brachial Blood Pressure Control 19
Left ventricular mass, left ventricular pump performance and cardiovascular events: the Strong Heart Study 18
Cardiovascular Predictors of Incident Heart Failure in Diabetes: the Strong Heart Study 17
Metabolic and cardiovascular characteristics of diabetes in adolescents and young adults: the Strong Heart Study 17
Impact of prescription of classes of antihypertensive medications on blood pressure control in the metabolic syndrome 17
Esame standard per protocolli scientifici 16
Influence of non-haemodynamic factors of left ventricular mass in adolescents with High prevalence of obesity: The Strong Heart Study. 16
Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients during Antihypertensive Treatment (from the LIFE Echo-Sbstudy) 15
Relation of ventricular geometry and function to age-related decline of renal function in a population without kidney failure: The Strong Heart Study 15
Diagnosis of metabolic syndrome based on history of exposure or present abnormalities: evidence of necessity of a better definition 15
Partial normalization of components of metabolic syndrome does not influence echocardiographic abnormalities: The HyperGEN Study. 15
Development of Systolic Dysfunction Not Related to Myocardial Infarction in Treated Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Echo Substud 14
Development of systolic disfunction not related to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy: the LIFE Echo Substudy 13
Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study 12
Exaggerated left ventricular adaptive response to obesity in women 11
Evidence for increased left ventricular chamber stiffness in type 2 diabetes: the Strong Heart Study. 11
Diabetes and incident heart failure: The Strong Heart Study. 10
Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension 10
null 7
Left ventricular mass, left ventricular pump performance and cardiovascular events: The Strong Heart Study. 6
Totale 2.421
Categoria #
all - tutte 9.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020185 82 0 20 0 20 0 1 0 3 1 32 26
2020/2021405 1 22 94 20 27 80 22 2 43 29 42 23
2021/2022408 26 2 1 5 1 11 0 13 96 11 46 196
2022/2023671 98 54 10 86 97 79 0 66 90 51 32 8
2023/2024374 12 52 20 24 38 73 2 63 0 12 67 11
Totale 2.421